pamidronate has been researched along with Interstitial Nephritis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Buysschaert, M | 1 |
| Cosyns, JP | 1 |
| Barreto, L | 1 |
| Jadoul, M | 1 |
| Janssen van Doorn, K | 1 |
| Neyns, B | 1 |
| Van der Niepen, P | 1 |
| Verbeelen, D | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Prevention of Bone Loss After Pediatric Hematopoietic Cell Transplantation[NCT02074631] | Phase 2 | 80 participants (Actual) | Interventional | 2015-02-28 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 other studies available for pamidronate and Interstitial Nephritis
| Article | Year |
|---|---|
Pamidronate-induced tubulointerstitial nephritis with Fanconi syndrome in a patient with primary hyperparathyroidism.
Topics: Aged; Biopsy, Needle; Diphosphonates; Fanconi Syndrome; Follow-Up Studies; Humans; Hyperparathyroidi | 2003 |
Pamidronate-related nephrotoxicity (tubulointerstitial nephritis) in a patient with osteolytic bone metastases.
Topics: Aged; Antineoplastic Agents; Bone Neoplasms; Breast Neoplasms; Diphosphonates; Female; Humans; Nephr | 2001 |